Dr. Reddy’s Files First Paragraph IV ANDA Against Teva’s 40mg Copaxone

Drug Industry Daily
Indian generics firm Dr. Reddy’s has filed the first patent challenge against Teva’s blockbuster multiple sclerosis drug Copaxone’s 40 mg, introducing a new chapter into the Israeli drugmaker’s efforts to protect its multibillion dollar product.

To View This Article:


Subscribe To Drug Industry Daily